SCHEMBL3845476

SCHEMBL3845476

CCCCCCCn1c(=O)c(NCCCOc2ccc(SC(C)(C)C(=O)O)cc2)nn(C)c1=O

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.39
SMPD1 P17405 1/20 0.36
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
PLA2G4A P47712 1/20 0.35
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.35
PDE4B Q07343 1/20 0.35
PLA2G4B P0C869 2/20 0.34
ADORA2B P29275 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3842655 0.91 MAPK14 (0.38) MAPK14SMPD1PPARGPPARAPLA2G4A
SCHEMBL3286654 0.91 MAPK14 (0.38) MAPK14SMPD1TSHRPDE4BALDH1A1
SCHEMBL3844355 0.86 PPARG (0.41) PPARGPPARATP53ADORA2BALDH1A1
SCHEMBL3841090 0.86 PPARG (0.47) SMPD1PPARGPPARA
SCHEMBL3842665 0.84 PPARG (0.46) PPARGPPARATSHRTP53PLA2G4B
SCHEMBL3846393 0.82 TP53 (0.39) PPARGPPARAPLA2G4ATSHRTP53
SCHEMBL3840290 0.81 PPARG (0.39) PPARGPPARATP53ADORA3
SCHEMBL3285407 0.81 PPARA (0.41) SMPD1PPARGPPARATSHRPDE4B
SCHEMBL3841974 0.80 PPARG (0.38) PPARGPPARAADORA3
SCHEMBL3284328 0.79 PPARG (0.34) PPARGPPARAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856065-B1 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY PF MEDICAMENT (FR) 2009-11-11 EP claimed
EP-1856065-B1 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY PF MEDICAMENT (FR) 2009-11-11 EP disclosed